학술논문

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Document Type
Article
Author
le Roux, Carel WAstrup, ArneFujioka, KenGreenway, FrankLau, David C WVan Gaal, LucOrtiz, Rafael ViolanteWilding, John P HSkjøth, Trine VManning, Linda ShapiroPi-Sunyer, XavierHamann, AndreasBarakat, AlainBlüher, MatthiasLinn, ThomasMölle, AndreaSegner, AlexanderStübler, PetraTosch-Sisting, ReginaPacini, FurioSantini, FerruccioMarchesini, GiulioRotella, Carlo MariaInvitti, CeciliaVettor, RobertoBuscemi, SilvioRaya, Pedro MezquitaFreijoo, Felipe Casanuevade Barbará, Ramón GomisCarraro, RaffaeleBobillo, Enrique Romerode la Cuesta, CarmenFarsang, CsabaCsaszar, AlbertZahorska-Markiewicz, BarbaraPupek-Musialik, DanutaFranek, EdwardOstrowska, LucynaOlszanecka-Glinianowicz, MagdalenaLalic, NebojsaMicic, DraganLudvik, BernhardPaulweber, BernhardPrager, RudolfScheen, AndréVan Gaal, LucAstrup, Arne VernonHermansen, KjeldMadsbad, StenRissanen, AilaNieminen, SakariSavolainen, MarkkuKrempf, MichelRomon, MoniqueLaville, MartineMarre, MichelMira, ReginaldFinucane, FrancisVeenendaal, Alethavan Berkum, FrankJohannsson-Vidarsdóttir, SolrunVan de Walle, VivienneMeesters, EelcoHjelmesæth, JøranKlemsdal, Tor OleKulseng, BårdBach-Kliegel, BirgitLaederach, KurtVilliger, LukasGolay, AlainBilz, StefanSathyapalan, ThozhukatBain, StephenKumar, SudeshLe Roux, Carel WynardLean, Michael E.J.McGowan, BarbaraRehman, TariqWilding, JohnWittert, GaryCaterson, IanProietto, JoesephPrins, JohnNeto, Bruno GelonezeGross, Jorge LuizChacra, Antonio RobertoHalpern, Alfredode Almeida Suplicy, HenriqueChow, Francis Chun ChungThacker, Hemant PChadha, ManojChandalia, HemarajUnnikrishnan, AmbikaKalra, SanjayDeshpande, NeetaShunmugavelu, MinakshiDeshmukh, Vaishali ChetanMaislos, MaximoLieberman, Gabriella SegalShimon, IlanStern, NaftaliNabriski, DanKarnieli, EddyShehadeh, NaimGonzalez-Galvez, Guillermodel Rosario Arechavaleta-Granell, MariaOrtiz, Rafael Margarito ViolanteFranco, Guadalupe MoralesGurieva, IrinaSuplotova, Lyudmila AleksandrovnaTroshina, EkaterinaRuyatkina, Ludmila AleksandrovnaVoychik, Emma AnatolievnaMartsevich, SergeyStartseva, Maria ASeeber, Mary ElizabethBadat, AyshaEllis, GrahamAltuntas, YukselGuler, SerdarUlgen, EnderDelibasi, TuncayChetty, TonyHart, RandyJanzen, JeannetteLabonte, IsabelleLau, DavidLiutkus, JoanneO'Keefe, DennisPadwal, RajRansom, Thomas P.P.Tytus, RichardWeisnagel, Stanley JohnAdler, JayAqua, KeithAronoff, Stephen LBedel, Gary W.Blevins, Thomas CraigBlumenau, JoeBrockmyre, Andrew PeterCall, Robert SCanadas, RafaelChaykin, Louis BCohen, KennethConrow, Jeffrey KeithDavis, Matthew GDowney, H JacksonDrosman, Steven RichardDuckor, StevenFarmer, H. FrankFarrell, JamesFehnel, StephenFinneran, Matthew PatrickForbes, RayForker, AlanFredrick, MarkFujioka, KenGeller, Steven AndrewGill, SantoshGlaser, LindaGreco, Susan NeimsGreenway, Frank LyonsHarper, WayneHerman, LeeHoekstra, JohnIngebretsen, RichardIson, RodneyJain, Rajeev KKaplan, RoyKaster, Steven RichardHaase, Gregory AKerzner, BorisKirstein, Judith LeeKoltun, WilliamKrieger, Diane RLewis, Cora ElizabethMadder, RobertMarple, Richard NMcDermott, Edward JMello, Curtis JohnMiller, Alan B.Mullen, JulieNardandrea, JohnO'Neil, PatrickPi-Sunyer, F. XavierPucillo, Ronald MRhee, ChanhaengRedrick, ScottPardini, AaronRothman, JeffreyRubino, Domenica MarieSellers, GladstoneSmith, TimothyByars, William DavidSoufer, JosephSussman, Allen MichaelPatrick, KyleSchramm, Erich LloydVan Cleeff, MartinBerg, Saul ReuelWyatt, Holly RoxannaSimon, James Alan
Source
The Lancet; April 2017, Vol. 389 Issue: 10077 p1399-1409, 11p
Subject
Language
ISSN
01406736; 1474547X
Abstract
Liraglutide 3·0 mg was shown to reduce bodyweight and improve glucose metabolism after the 56-week period of this trial, one of four trials in the SCALE programme. In the 3-year assessment of the SCALE Obesity and Prediabetes trial we aimed to evaluate the proportion of individuals with prediabetes who were diagnosed with type 2 diabetes.